Dr. Barry Dworkin

It stands to reason that most medications designed to manage progressive chronic disease once discontinued will see a relapse or progression of said disease process.

Medical Mythbusting Commentary for March 25, 2026

Source:
Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds

Reference:
GLP-1RA discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: A target emulation trial.

Related posts:

  1. The decision to use cholesterol-lowering statins requires full cardiovascular risk assessment
  2. Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.
  3. Battle With Heart Disease Moves to the Doctor's Office but what about the grocery store?
  4. Erectile dysfunction as a predictor of heart disease